Molecular Modelling and 1H-NMR: Ultimate Tools for the Investigation of Tolbutamide: .BETA.-Cyclodextrin and Tolbutamide: Hydroxypropyl-.BETA.-Cyclodextrin Complexes.-Reference-Cited by-同舟云学术

Molecular Modelling and 1H-NMR: Ultimate Tools for the Investigation of Tolbutamide: .BETA.-Cyclodextrin and Tolbutamide: Hydroxypropyl-.BETA.-Cyclodextrin Complexes.

Published:2001 Issue:10 Volume:49 Page:1251-1256
ISSN:0009-2363
Container-title:Chemical and Pharmaceutical Bulletin
language:en
Short-container-title:CHEMICAL & PHARMACEUTICAL BULLETIN

Author:

VEIGA Francisco José Baptista¹,FERNANDES Catarina Marques¹,CARVALHO Rui Albuquerque²,GERALDES Carlos Frederico Gusmao Campos²

Affiliation:

1. Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra

2. Department of Biochemistry, University of Coimbra

Publisher

Pharmaceutical Society of Japan

Subject

Drug Discovery,General Chemistry,General Medicine

Link

http://www.jstage.jst.go.jp/article/cpb/49/10/49_10_1251/_pdf

Reference33 articles.

1. 1) Szejtli J. (ed.), “Cyclodextrin Technology,” Kluwer, Dordrecht, 1988, pp.1-78.

2. Cyclodextrin Inclusion Compounds in Research and Industry

3. Cyclodextrins

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colloidal nanoparticles of a β-cyclodextrin/L-Tryptophan inclusion complex for use as Pickering emulsion stabilizers;Food Hydrocolloids;2025-02

2. Supramolecular encapsulation of nanocrystalline Schiff bases into β-cyclodextrin for multifold enrichment of bio-potency;Carbohydrate Polymers;2022-09

3. Determination of inclusion geometry of cyclodextrin host-guest complexes: Applicability of 1D selective NMR methods;Journal of Magnetic Resonance Open;2022-06

4. Enhanced Antioxidant, Antiviral, and Anticancer Activities of the Extract of Fermented Egyptian Rice Bran Complexed with Hydroxypropyl-β-cyclodextrin;ACS Omega;2022-06-01

5. Supramolecular Complexes of Plant Neurotoxin Veratridine with Cyclodextrins and Their Antidote-like Effect on Neuro-2a Cell Viability;Pharmaceutics;2022-03-09